Inappropriate upregulation of
cyclooxygenase-2 (COX-2) and
matrix metalloproteinases (
MMPs) has been implicated in the pathogenesis of various types of
cancer. In the present study, we investigated the effects of
hirsutenone, a
diarylheptanoid isolated from the medicinal plant Alnus hirsuta var. sibirica, on the expression of COX-2 and MMP-9 induced by the
tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) in MCF10A human breast epithelial cells. Treatment of MCF10A cells with TPA led to the expression of COX-2 and MMP-9.
Hirsutenone at 12 microM inhibited the TPA-induced COX-2 expression at both the transcriptional and posttranscriptional levels.
Hirsutenone also suppressed the synthesis of
prostaglandin E(2), one of the major products of COX-2, and its catalytic activity. The upregulation of MMP-9 by TPA was also significantly reduced by
hirsutenone. Likewise,
hirsutenone attenuated the invasiveness and motility of MCF10A cells stimulated with TPA.
Hirsutenone blocked the TPA-induced
DNA binding of
nuclear factor kappa B (
NF-kappaB) and translocation of p65, the functionally active
NF-kappaB subunit, to the nucleus. The
luciferase reporter gene assay revealed that
hirsutenone abrogated the transcriptional activity of
NF-kappaB. Treatment of MCF10A cells with N-alpha-Tosyl-
l-phenylalanine chloromethyl
ketone, a specific inhibitor of
NF-kappaB, reduced the TPA-induced expression of COX-2 and MMP-9. In summary,
hirsutenone inhibits the TPA-induced upregulation of COX-2 and MMP-9 in human breast epithelial cells, possibly by targeting
NF-kappaB, which may contribute to its chemopreventive effects.